Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients
Kazakh Institute of Oncology and Radiology
Kazakh Institute of Oncology and Radiology
University of Utah
Ottawa Hospital Research Institute
Assistance Publique - Hôpitaux de Paris
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Celgene
OHSU Knight Cancer Institute
University Hospital, Brest
Albert Einstein College of Medicine
Cairo University
Eastern Cooperative Oncology Group
TidalSense
Eurasian Association of Therapists
Merck Sharp & Dohme LLC
Kyntra Bio
King Hussein Cancer Center
Celgene
Dartmouth-Hitchcock Medical Center
Sunnybrook Health Sciences Centre
Weprom
City of Hope Medical Center
Radiation Therapy Oncology Group
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
University of Aarhus
National Cancer Center, Korea
Hospital Universitari de Bellvitge
M.D. Anderson Cancer Center
University of Maryland, Baltimore
National Cancer Institute (NCI)
Wirral University Teaching Hospital NHS Trust
Stanford University
Masimo Corporation
University Hospital, Montpellier
Mayo Clinic
Amgen
Eli Lilly and Company
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
German CLL Study Group
Janssen Research & Development, LLC
The Cleveland Clinic
American Regent, Inc.
University of North Carolina, Chapel Hill
Tarix Pharmaceuticals
Sandoz
GOG Foundation
Hoffmann-La Roche
Post Graduate Institute of Medical Education and Research, Chandigarh